Skip to main content
. 2018 Oct 8;10(4):179. doi: 10.3390/pharmaceutics10040179

Table 4.

Phase composition of samples determined by DIFFRAC.EVA analysis of X-ray diffraction (XRD) patterns.

Sample Name Ca10-xSrx(PO4)6(OH)2
(%)
CaO
(%)
CaCO3
(%)
0mSrHANFs 66.3 21.1 12.6
1mSrHANFs 77.5 21.5 1.0
2mSrHANFs 83.4 15.8 0.8
3mSrHANFs 96.1 1.4 2.5